ARMEN GARO H 4

4 · AGENUS INC · Filed Mar 24, 2026

AI-generated summary of this filing

Updated Mar 24, 2026

Agenus CEO Garo H. Armen Receives Award of 3,983 Shares

What Happened

Garo H. Armen, Chairman, Chief Executive Officer and Principal Financial Officer of Agenus Inc. (AGEN), was issued 3,983 shares of common stock as salary paid in stock (transaction code A) on March 20, 2026. The shares were valued at $3.71 each, for a total value of $14,777.
These shares were issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive plan and were fully vested on the date of issuance.

Key Details

Transaction date: 2026-03-20; Filing date: 2026-03-24 (filed on time).
Price used: $3.71 per share (closing price on 3/20/2026); total value ~$14,777.
Shares issued as salary (paid in stock) and delivered net to Dr. Armen’s IRA accounts.
Not an open-market purchase or sale—this is compensation converted to equity (award/grant).
Disclosed related holdings: Dr. Armen is trustee and has investment authority for 23,950 shares held by the Garo Armen 2020 2 Year AG GRAT; Pixie Partners (a partnership where he is a general partner) owns 5,000 shares, though he disclaims beneficial ownership to the extent of his pecuniary interest.

Context

This issuance reflects salary paid in company stock rather than a market transaction; it is compensation and does not necessarily signal a personal buy or sell decision.
The shares are fully vested on issuance, so there are no vesting contingencies for these shares.

Form 4

Period: 2026-03-20

DirectorSee Remarks

Transactions

Holdings

Footnotes (4)

[F1]At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending March 20, 2026. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.
[F2]$3.71 is the closing price of our Common Stock on March 20, 2026, the last trading day for the payroll date for the pay period ending March 20, 2026.
[F3]Shares are held in Dr. Armen's IRA accounts.
[F4]Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.

Signature

/s/ Austin Charette, as Attorney-in-Fact for Garo H. Armen|2026-03-24

1 file